Shanghai Xiao Fang Pharmaceutical Co (SHSE:603207) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603207 Shanghai Xiao Fang Pharmaceutical Co Ltd SHSE:603207
41 GF Score
Price ¥23.09
! 3 Warning Signs
View Full Analysis

What is Shanghai Xiao Fang Pharmaceutical Co Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

SHSE:603207
41GF Score
Shanghai Xiao Fang Pharmaceutical Co Ltd SHSE:603207
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Xiao Fang Pharmaceutical Co Business Description

Address No. 777, Hongzhu Road, Fengxian District, Shanghai, CHN, 201411
Shanghai Xiao Fang Pharmaceutical Co Ltd is engaged in Research and development, production and sales of topical medicines.
41GF Score

Get the complete analysis for SHSE:603207

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥23.09
Price